Financial PerformanceThe company's robust EBITDA growth prospects, both organic and inorganic, coupled with a strong free cash flow conversion rate of over 50%, make it an attractive investment.
Investment OpportunitiesThe stock has been weak since the spin, providing an excellent opportunity to buy this quality stock.
Market PositionAmrize's dominant position and exposure to structurally strong inland markets gives superior pricing power.